These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
412 related articles for article (PubMed ID: 23435786)
21. Cationic Compounds with SARS-CoV-2 Antiviral Activity and Their Interaction with Organic Cation Transporter/Multidrug and Toxin Extruder Secretory Transporters. Martinez-Guerrero L; Zhang X; Zorn KM; Ekins S; Wright SH J Pharmacol Exp Ther; 2021 Oct; 379(1):96-107. PubMed ID: 34253645 [TBL] [Abstract][Full Text] [Related]
22. Double-transfected MDCK cells expressing human OCT1/MATE1 or OCT2/MATE1: determinants of uptake and transcellular translocation of organic cations. König J; Zolk O; Singer K; Hoffmann C; Fromm MF Br J Pharmacol; 2011 Jun; 163(3):546-55. PubMed ID: 20883471 [TBL] [Abstract][Full Text] [Related]
23. Changes of drug pharmacokinetics mediated by downregulation of kidney organic cation transporters Mate1 and Oct2 in a rat model of hyperuricemia. Nishizawa K; Yoda N; Morokado F; Komori H; Nakanishi T; Tamai I PLoS One; 2019; 14(4):e0214862. PubMed ID: 30951542 [TBL] [Abstract][Full Text] [Related]
24. Physiological and pharmacokinetic roles of H+/organic cation antiporters (MATE/SLC47A). Terada T; Inui K Biochem Pharmacol; 2008 May; 75(9):1689-96. PubMed ID: 18262170 [TBL] [Abstract][Full Text] [Related]
25. SLC22, SLC44, and SLC47 transporters--organic anion and cation transporters: molecular and cellular properties. Pelis RM; Wright SH Curr Top Membr; 2014; 73():233-61. PubMed ID: 24745985 [TBL] [Abstract][Full Text] [Related]
26. Contribution of MATE1 to Renal Secretion of the NMDA Receptor Antagonist Memantine. Müller F; Weitz D; Derdau V; Sandvoss M; Mertsch K; König J; Fromm MF Mol Pharm; 2017 Sep; 14(9):2991-2998. PubMed ID: 28708400 [TBL] [Abstract][Full Text] [Related]
27. Competitive inhibition of the luminal efflux by multidrug and toxin extrusions, but not basolateral uptake by organic cation transporter 2, is the likely mechanism underlying the pharmacokinetic drug-drug interactions caused by cimetidine in the kidney. Ito S; Kusuhara H; Yokochi M; Toyoshima J; Inoue K; Yuasa H; Sugiyama Y J Pharmacol Exp Ther; 2012 Feb; 340(2):393-403. PubMed ID: 22072731 [TBL] [Abstract][Full Text] [Related]
29. Polyspecific organic cation transporters and their impact on drug intracellular levels and pharmacodynamics. Wagner DJ; Hu T; Wang J Pharmacol Res; 2016 Sep; 111():237-246. PubMed ID: 27317943 [TBL] [Abstract][Full Text] [Related]
30. Polyspecific organic cation transporters and their biomedical relevance in kidney. Koepsell H Curr Opin Nephrol Hypertens; 2013 Sep; 22(5):533-8. PubMed ID: 23852330 [TBL] [Abstract][Full Text] [Related]
31. Role of organic cation transporters in drug-drug interaction. Koepsell H Expert Opin Drug Metab Toxicol; 2015; 11(10):1619-33. PubMed ID: 26206523 [TBL] [Abstract][Full Text] [Related]
32. Transport of drugs in the kidney by the human organic cation transporter, OCT2 and its genetic variants. Fujita T; Urban TJ; Leabman MK; Fujita K; Giacomini KM J Pharm Sci; 2006 Jan; 95(1):25-36. PubMed ID: 16307453 [TBL] [Abstract][Full Text] [Related]
33. Pharmacokinetics and Toxicokinetics Roles of Membrane Transporters at Kidney Level. Veiga-Matos J; Remião F; Motales A J Pharm Pharm Sci; 2020; 23():333-356. PubMed ID: 32997956 [TBL] [Abstract][Full Text] [Related]
34. Different effect of testosterone and oestrogen on urinary excretion of metformin via regulating OCTs and MATEs expression in the kidney of mice. He R; Ai L; Zhang D; Wan L; Zheng T; Yin J; Lu H; Lu J; Lu F; Liu F; Jia W J Cell Mol Med; 2016 Dec; 20(12):2309-2317. PubMed ID: 27469532 [TBL] [Abstract][Full Text] [Related]
35. Altered pharmacokinetics of cationic drugs caused by down-regulation of renal rat organic cation transporter 2 (Slc22a2) and rat multidrug and toxin extrusion 1 (Slc47a1) in ischemia/reperfusion-induced acute kidney injury. Matsuzaki T; Morisaki T; Sugimoto W; Yokoo K; Sato D; Nonoguchi H; Tomita K; Terada T; Inui K; Hamada A; Saito H Drug Metab Dispos; 2008 Apr; 36(4):649-54. PubMed ID: 18180268 [TBL] [Abstract][Full Text] [Related]
36. Farnesoid X Receptor Activation Stimulates Organic Cations Transport in Human Renal Proximal Tubular Cells. Wongwan T; Chatsudthipong V; Soodvilai S Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32846898 [TBL] [Abstract][Full Text] [Related]
37. In Vitro Inhibition of Renal OCT2 and MATE1 Secretion by Antiemetic Drugs. George B; Wen X; Jaimes EA; Joy MS; Aleksunes LM Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34208557 [TBL] [Abstract][Full Text] [Related]
38. A Whole-Body Physiologically Based Pharmacokinetic Model Characterizing Interplay of OCTs and MATEs in Intestine, Liver and Kidney to Predict Drug-Drug Interactions of Metformin with Perpetrators. Yang Y; Zhang Z; Li P; Kong W; Liu X; Liu L Pharmaceutics; 2021 May; 13(5):. PubMed ID: 34064886 [TBL] [Abstract][Full Text] [Related]
39. Imatinib Uptake into Cells is Not Mediated by Organic Cation Transporters OCT1, OCT2, or OCT3, But is Influenced by Extracellular pH. Blanc Mettral J; Faller N; Cruchon S; Sottas L; Buclin T; Schild L; Choong E; Nahimana A; Decosterd LA Drug Metab Lett; 2019; 13(2):102-110. PubMed ID: 30734690 [TBL] [Abstract][Full Text] [Related]
40. Organic Cation Transporters in Human Physiology, Pharmacology, and Toxicology. Samodelov SL; Kullak-Ublick GA; Gai Z; Visentin M Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33114309 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]